Dalriada brings in former Evotec executive Adam Davenport to lead strategy execution as Chief R&D Officer TORONTO, May 03, 2023 (GLOBE NEWSWIRE) -- Dalriada, a leading Canadian contract research organization specializing in small molecule therapies, announces today that it has strengthened its executive...

Dalriada further strengthens small molecule discovery expertise with appointment of veteran Dr. Frosty Loechel as SVP Biology, Discovery Strategy group TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Dalriada, a leading Canadian contract research organization specializing in small molecule therapies, announces today the appointment of Frosty Loechel,...